Scientists have uncovered a dedicated brain circuit that distinguishes between direct fear and fear learned by observing others—known as vicarious fear.

A new large language model framework teaches LLMs to use an optimization solving algorithm to resolve complex, multistep planning tasks. With the LLMFP framework, someone can input a natural language description of their problem and receive a plan to reach their desired goal.

An Arlington-based venture capital firm has announced it will pour $32 million in funding into cybersecurity startups.

Runtime Ventures, based out of Arlington and Austin, Texas, officially announced the capital commitment today (Wednesday).

It has already made 11 investments from the fund so far, supporting seed-stage cybersecurity companies focused on domains including code analysis, fraud protection, threat detection and browser security.

The bill will allow Japan to implement safeguards and strategies that have been in use by other countries for some time.

Atsena Therapeutics has raised $150 million in an oversubscribed series C financing, with hopes that the funds can carry the biotech’s gene therapy designed to reverse or prevent blindness through a potential market approval.

The funding round was led by new investor Bain Capital, with participation from Sofinnova Investments, Abingworth, Wellington Management, Lightstone Ventures, Foundation Fighting Blindness, Hatteras Venture Partners, Osage University Partners and the Manning Family Foundation, according to an April 2 release.

It took decades to notice.

Discover groundbreaking advancements in Alzheimer’s research, focusing on secretory dysfunction and innovative therapeutic approaches.

Could Short Chains of Amino Acids Revolutionize Anti-aging? We explore the exciting potential of peptide therapy to address key hallmarks of aging, including biological age and telomere length. This video delves into the science behind peptides and examines early clinical findings that suggest significant possibilities for age reversal.

What you’ll learn:
• Key peptides being studied for anti-aging (Epitalon, GHK-Cu, etc.).
• A look at clinical studies and patient data.
• The future of peptide therapy in longevity research.

Credits to : glycanage, dr. luis martinez of clinical peptide society

Please note that the links below are affiliate links, so we receive a small commission when you purchase a product through the links. Thank you for your support!
=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=
ProHealth, RENUE, DoNotAge, StemRegen, N1O1, NOVOS Coupon CODE: REVERSE

Activate Your Stem Cells Naturally — STEMREGEN 15% OFF https://tinyurl.com/StemRelease.

Dr Bryan Nitric Oxide Supplement 20% OFF Code LAFIRE

A general reinforcement-learning algorithm, called Dreamer, outperforms specialized expert algorithms across diverse tasks by learning a model of the environment and improving its behaviour by imagining future scenarios.

When your social media account starts spewing out nonsensical or threatening status updates, it’s safe to assume that it has been hacked and must be shut down.

The cells in our body also update their “status” by presenting to their environment small proteins that are constantly being produced inside the cell. Our immune system monitors these statuses and destroys cells that produce unusual proteins. A classic example of this is when a cell is infected by a virus and presents parts of the viral proteins on its surface, which allows the immune system to recognize them and destroy the cell.

In contrast, cancer cells often evade detection by displaying very few suspicious proteins that the immune system can identify and target. A new approach to cancer treatment, developed by researchers from Prof. Yardena Samuels’s lab at the Weizmann Institute of Science, increases the number of the immune system’s targets by disrupting protein production in cancerous cells.